BioMarin Pharmaceutical filed a report with the Securities and Exchange Commission on July 24, 2026.
3 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioMarin Pharmaceutical filed a report with the Securities and Exchange Commission on July 24, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioMarin Pharmaceutical
American company
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- BioTech filed a registration statement with the Securities and Exchange Commission on October 7, 2026.
- 60 Degrees Pharmaceuticals, Inc. filed a registration statement with the Securities and Exchange Commission on July 17, 2025.
- Quince Therapeutics plans to file its financial results with the Securities and Exchange Commission.
- Citadel Advisors LLC bought a new stake in Baird Medical Investment Holdings Limited and filed a 13F with the SEC.